After a recent announcement from Novo Nordisk I cleared my schedule to record this episode with Dr. Todd Hobbs, Chief Medical Officer for North America and Ken Inchausti, Senior Director of Corporate Communications. In this open discussion they share resources and cost saving programs, details about insulin production, insulin trials and what’s on the horizon for insulin therapies. I learned SO much about a drug I’ve been taking for decades!
Rolling into the second half of my 34th year of living with Type 1 diabetes, I can’t help but reflect on what has led me to my current state of T1D affairs. It wasn’t until meeting fellow Diabetes Daily Grind co-founder, Ryan, that I began talking about my life with the disease. This journey has brought on an incredible number of “ah-ha” moments, recognition of suppressed anger and “moving on” milestones. Continue reading →